LYRM1 antibody (Center)
Quick Overview for LYRM1 antibody (Center) (ABIN783590)
Target
See all LYRM1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Center
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, mouse, rat
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 17 amino acid peptide near the center of human LYRM1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- LYRM1 (LYR Motif Containing 1 (LYRM1))
-
Alternative Name
- LYRM1
-
Background
- LYRM1 was one of many genes identified through a suppression subtractive hybridization comparing their expression in omental adipose tissue of obese patients compared to non-obese individuals. Further study confirms that both mRNA and protein levels of LYRM1 are higher in obese individuals. LYRM1 is widely expressed, with highest levels occurring in adipose and liver tissues. It is thought that LYRM1 promotes preadipocyte proliferation and can inhibit apoptosis of preadipocytes. Ectopic LYRM1 expression did not significantly affect adipogenesis, suggesting that LYRM1 can influence adipose tissue homeostasis by modulating the size of the preadipocyte pool.Synonyms: LYR motif-containing protein 1
-
Gene ID
- 57149
-
NCBI Accession
- NP_001121773
-
UniProt
- O43325
Target
-